Superworth

Achieve Life Sciences EPS ACHV

Diluted earnings per share by quarter and over the last twelve months, from 2010.

Last 12 months, to Jun 30, 2026
−$1.54
Latest quarter, Q2 FY26
−$0.80
Fiscal year 2025
−$1.29

Achieve Life Sciences' earnings per share was −$1.54 over the twelve months to Jun 30, 2026.

In its latest quarter, Q2 FY26, it was −$0.80.

Earnings per share over time

Open the interactive chart, with overlays and comparisons

Fiscal year by fiscal year

Fiscal yearEPSChange
FY2025−$1.29n/a
FY2024−$1.23n/a
FY2023−$1.53n/a
FY2022−$4.06n/a
FY2021−$4.30n/a
FY2020−$6.08n/a
FY2019−$42.63n/a
FY2018−$110.20n/a
FY2017−$18095.00n/a
FY2016−$11624.00n/a
FY2015−$1496.00n/a
FY2014−$3410.00n/a
FY2013−$4752.00n/a
FY2012−$3608.00n/a
FY2011−$1958.00n/a

Each fiscal year is the twelve months to its fourth quarter.

Quarter by quarter

QuarterEndedEPSOn a year earlierLast 12 months
Q2 FY26−$0.80n/a−$1.54
Q1 FY26−$0.19n/a−$1.11
Q4 FY25−$0.27n/a−$1.29
Q3 FY25−$0.28n/a−$1.38
Q2 FY25−$0.37n/a−$1.46
Q1 FY25−$0.37n/a−$1.34
Q4 FY24−$0.36n/a−$1.23
Q3 FY24−$0.36n/a−$1.13
Q2 FY24−$0.25n/a−$1.11
Q1 FY24−$0.26n/a−$1.29
Q4 FY23−$0.26n/a−$1.53
Q3 FY23−$0.34n/a−$2.10

Against its peers

Companies in Medical - Diagnostics & Research nearest Achieve Life Sciences' size, closest first, today.

CompanyEPS, 12 monthsGrowth
ACHVAchieve Life Sciences−$1.54
NRCNRC Health$0.25−67% a year
CDNACareDx$2.07+116% a year
VCYTVeracyte$1.40+324% a year
ICCCImmucell$0.08−58% a year
BLLNBillionToOne$0.65
LNTHLantheus$4.13+10% a year
Peer median$1.02

What the EPS figure tells you

Net income divided by diluted shares. The denominator of PE.

One-off charges and gains swing it. The TTM view smooths a single odd quarter.

More on Achieve Life Sciences

Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.